Experienced in Allergic Conjunctivitis

Dr. Marc Rothenberg

Pediatrics
Cincinnati Children's Hospital Medical Center
3333 Burnet Ave, 
Cincinnati, OH 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Allergic Conjunctivitis
Cincinnati Children's Hospital Medical Center
3333 Burnet Ave, 
Cincinnati, OH 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Marc Rothenberg is a Pediatrics provider in Cincinnati, Ohio. Dr. Rothenberg is rated as an Experienced provider by MediFind in the treatment of Allergic Conjunctivitis. His top areas of expertise are Eosinophilic Esophagitis, Eosinophilic Enteropathy, Eosinophilic Colitis, Endoscopy, and Tissue Biopsy.

His clinical research consists of co-authoring 351 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Allergic Conjunctivitis.

Specialties
Pediatrics
Licenses
Allergy & Immunology in OH
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

CareSource
  • HMO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medical Health
  • HMO
  • PPO

Locations

Cincinnati Children's Hospital Medical Center
3333 Burnet Ave, Cincinnati, OH 45229

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Prospective, Multicenter Study to Compare and Validate Endoscopic, Histologic, Molecular, and Patient-Reported Outcomes in Pediatric and Adult Patients With Eosinophilic Esophagitis (EoE), Gastritis (EoG), Enteritis (EoN) and Colitis (EoC)
A Prospective, Multicenter Study to Compare and Validate Endoscopic, Histologic, Molecular, and Patient-Reported Outcomes in Pediatric and Adult Patients With Eosinophilic Esophagitis (EoE), Gastritis (EoG), Enteritis (EoN) and Colitis (EoC)
Enrollment Status: Recruiting
Publish Date: September 12, 2025
A Phase 3, 52-week, Open-label, Single Arm Study to Investigate the Efficacy and Safety of Mepolizumab SC in Participants Aged 6 to 17 Years With Hypereosinophilic Syndrome
A Phase 3, 52-week, Open-label, Single Arm Study to Investigate the Efficacy and Safety of Mepolizumab SC in Participants Aged 6 to 17 Years With Hypereosinophilic Syndrome
Enrollment Status: Completed
Publish Date: December 04, 2025
Intervention Type: Drug
Study Drug: Mepolizumab
Study Phase: Phase 3
A Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy of Dupilumab (Anti-IL4a) in Subjects With Eosinophilic Gastritis
A Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy of Dupilumab (Anti-IL4a) in Subjects With Eosinophilic Gastritis
Enrollment Status: Completed
Publish Date: November 04, 2025
Intervention Type: Drug
Study Drug: Dupilumab
Study Phase: Phase 2
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamic Effect of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamic Effect of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis
Enrollment Status: Completed
Publish Date: January 19, 2024
Intervention Type: Other, Drug
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy of Benralizumab (Anti-IL5RA) in Subjects With Eosinophilic Gastritis
A Randomized, Double-Blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy of Benralizumab (Anti-IL5RA) in Subjects With Eosinophilic Gastritis
Enrollment Status: Completed
Publish Date: February 03, 2022
Intervention Type: Biological
Study Drug: Benralizumab
Study Phase: Phase 2/Phase 3
Demographics, Clinical Characteristics, and Pathology of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Demographics, Clinical Characteristics, and Pathology of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Enrollment Status: Completed
Publish Date: September 28, 2021
A Multi-centre, Open-label Extension, Safety Study to Describe the Long-term Clinical Experience of Mepolizumab in Participants With Hypereosinophilic Syndrome (HES) From Study 200622
A Multi-centre, Open-label Extension, Safety Study to Describe the Long-term Clinical Experience of Mepolizumab in Participants With Hypereosinophilic Syndrome (HES) From Study 200622
Enrollment Status: Completed
Publish Date: June 23, 2020
Intervention Type: Drug
Study Phase: Phase 3
Six Food vs One Food Eosinophilic Esophagitis Elimination Diet (SOFEED) Followed by Swallowed Glucocorticoid Trial
Six Food vs One Food Eosinophilic Esophagitis Elimination Diet (SOFEED) Followed by Swallowed Glucocorticoid Trial
Enrollment Status: Completed
Publish Date: May 26, 2020
Intervention Type: Other, Drug
Study Phase: Phase 2/Phase 3
View 7 Less Clinical Trials

351 Total Publications

Immune Functions of the Esophagus.
Immune Functions of the Esophagus.
Journal: The Journal of allergy and clinical immunology
Published: October 20, 2025
Similar Doctors
Advanced in Allergic Conjunctivitis
Dr. Roua Azmeh
Pediatrics
Advanced in Allergic Conjunctivitis
Dr. Roua Azmeh
Pediatrics

Kettering Pediatric & Family Care Inc.

5250 Far Hills Ave Ste 260, 
Dayton, OH 
 (41.7 miles away)
937-293-4053
Languages Spoken:
English
See accepted insurances

Roua Azmeh is a Pediatrics provider in Dayton, Ohio. Dr. Azmeh is rated as an Advanced provider by MediFind in the treatment of Allergic Conjunctivitis. Her top areas of expertise are Chronic Spontaneous Urticaria (CSU), Vibratory Urticaria, Allergic Rhinitis, and Allergic Conjunctivitis.

Experienced in Allergic Conjunctivitis
Dr. Heidy Martinez
Ophthalmology | Pediatrics
Experienced in Allergic Conjunctivitis
Dr. Heidy Martinez
Ophthalmology | Pediatrics

Children's Hospital Medical Center

3333 Burnet Ave, 
Cincinnati, OH 
 (0.1 miles away)
513-636-4200
Languages Spoken:
English
See accepted insurances

Heidy Martinez is an Ophthalmologist and a Pediatrics provider in Cincinnati, Ohio. Dr. Martinez is rated as an Advanced provider by MediFind in the treatment of Allergic Conjunctivitis. Her top areas of expertise are Hyphema, Strabismus, Blocked Tear Duct, and Esotropia.

Experienced in Allergic Conjunctivitis
Dr. Ann Ghory
Pediatrics
Experienced in Allergic Conjunctivitis
Dr. Ann Ghory
Pediatrics

Office

7495 State Rd Ste 350, 
Cincinnati, OH 
 (10.8 miles away)
513-861-0222
Languages Spoken:
English
See accepted insurances

Ann Ghory is a Pediatrics provider in Cincinnati, Ohio. Dr. Ghory is rated as an Advanced provider by MediFind in the treatment of Allergic Conjunctivitis. Her top areas of expertise are Allergic Rhinitis, Sinusitis, Common Variable Immune Deficiency, and Hives.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Rothenberg's expertise for a condition
ConditionClose
View All 14 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile